7 Citations (Scopus)
24 Downloads (Pure)

Abstract

This study compared acute supplementation of Montmorency tart cherries in capsule (MTCC) and juice (MTCJ) forms in MetS humans, as potential prophylactic interventions against cardio-metabolic diseases. In an acute, single-blind, placebo-controlled, randomised, crossover trial, eleven participants with MetS (49 ± 12 years; 6M/5F), consumed one bolus of MTCC, MTCJ or placebo (PLA) on different occasions. Blood-based and functional cardio-metabolic biomarkers were measured pre-bolus and up to 5 h post-bolus. MTCJ significantly reduced systolic blood pressure compared to PLA at 2-h post-bolus (P = 0.018). Insulin was significantly lower with MTCC (P = 0.016) and MTCJ (P = 0.028) than PLA at 1-h and 3-h post-bolus, respectively. No significant differences between MTCC and MTCJ were seen. This study demonstrated for the first time that MTCC could reduce insulin concentrations in humans. Importantly, MTCJ induced a clinically relevant reduction in systolic blood pressure and also lowered insulin compared to PLA, in MetS humans.
Original languageEnglish
Pages (from-to)286-298
Number of pages13
JournalJournal of Functional Foods
Volume57
Issue numberJune 2019
DOIs
Publication statusPublished - 16 Apr 2019

Keywords

  • Anthocyanins
  • Cardiometabolic health
  • Diabetes
  • Functional foods
  • Hypertension
  • Polyphenols

Fingerprint

Dive into the research topics of 'Effects of Montmorency Tart Cherry Supplementation on Cardio-Metabolic Markers in Metabolic Syndrome Participants: a pilot study'. Together they form a unique fingerprint.

Cite this